Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond

Cites (237)

Items 201–237 of 237

1. Structures of Cryptococcus neoformans Protein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal Pathogens
   Michael A. Hast, Connie B. Nichols, Stephanie M. Armstrong, Shannon M. Kelly, Homme W. Hellinga, J. Andrew Alspaugh, Lorena S. Beese · 2011 · Journal of Biological Chemistry
2. Plasma Membrane Localization Is Required for RasA-Mediated Polarized Morphogenesis and Virulence of Aspergillus fumigatus
   Jarrod R. Fortwendel, Praveen R. Juvvadi, Luise E. Rogg, Yohannes G. Asfaw, Kimberlie A. Burns, Scott H. Randell, William J. Steinbach · 2012 · Eukaryotic Cell
3. Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex
   Cordeiro, Rossana de Aguiar, Evangelista, Antonio José de Jesus, Serpa, Rosana, Marques, Francisca Jakelyne de Farias, Melo, Charlline Vládia Silva de, Oliveira, Jonathas Sales de, Franco, Jônatas da Silva, Alencar, Lucas Pereira de, Bandeira, Tereza de Jesus Pinheiro Gomes, Brilhante, Raimunda Sâmia Nogueira et al. · 2016 · Microbiology
4. Design and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors
   David S. Huang, Emmanuelle V. LeBlanc, Tanvi Shekhar‐Guturja, Nicole Robbins, Damian J. Krysan, J.C. Pizarro, Luke J. Whitesell, Leah E. Cowen, Lauren E. Brown · 2019 · Journal of Medicinal Chemistry
5. Local silencing controls the oxidative stress response and the multidrug resistance in <i> <scp>C</scp> andida glabrata </i>
   Orta‐Zavalza, Emmanuel, Guerrero‐Serrano, Gehenna, Gutiérrez‐Escobedo, Guadalupe, Cañas‐Villamar, Israel, Juárez‐Cepeda, Jacqueline, Castaño, Irene, De Las Peñas, Alejandro · 2013 · Molecular Microbiology
6. Chromosome 5 Monosomy of Candida albicans Controls Susceptibility to Various Toxic Agents, Including Major Antifungals
   Yang, Feng, Kravets, Anatoliy, Bethlendy, Gabor, Welle, Stephen, Rustchenko, Elena · 2013 · Antimicrobial Agents and Chemotherapy
7. The Candida albicans transcription factor Cas5 couples stress responses, drug resistance and cell cycle regulation
   Xie, Jinglin L., Qin, Longguang, Miao, Zhengqiang, Grys, Ben T., Diaz, Jacinto De La Cruz, Ting, Kenneth, Krieger, Jonathan R., Tong, Jiefei, Tan, Kaeling, Leach, Michelle D. et al. · 2017 · Nature Communications
8. Rapid and extensive karyotype diversification in haploid clinical Candida auris isolates
   Bravo Ruiz, Gustavo, Ross, Zoe K., Holmes, Eilidh, Schelenz, Silke, Gow, Neil A. R., Lorenz, Alexander · 2019 · Current Genetics
9. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29
   Tanvi Shekhar‐Guturja, Walters Aji Tebung, Harley O’Connor Mount, Ning-Ning Liu, Julia R. Köhler, Malcolm S. Whiteway, Leah E. Cowen · 2016 · Antimicrobial Agents and Chemotherapy
10. Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling
    Khandelwal, Nitesh Kumar, Chauhan, Neeraj, Sarkar, Parijat, Esquivel, Brooke D., Coccetti, Paola, Singh, Ashutosh, Coste, Alix T., Gupta, Meghna, Sanglard, Dominique, White, Theodore C. et al. · 2018 · Journal of Biological Chemistry
11. Overcoming Fungal Echinocandin Resistance through Inhibition of the Non-essential Stress Kinase Yck2
    Caplan, Tavia, Lorente-Macías, Álvaro, Stogios, Peter J., Evdokimova, Elena, Hyde, Sabrina, Wellington, Melanie A., Liston, Sean, Iyer, Kali R., Puumala, Emily, Shekhar-Guturja, Tanvi et al. · 2020 · Cell Chemical Biology
12. Functional Genomic Screening Reveals Core Modulators of Echinocandin Stress Responses in Candida albicans
    Caplan, Tavia, Polvi, Elizabeth J., Xie, Jinglin L., Buckhalter, Shoshana, Leach, Michelle D., Robbins, Nicole, Cowen, Leah E. · 2018 · Cell Reports
13. FKS2 and FKS3 Genes of Opportunistic Human Pathogen Candida albicans Influence Echinocandin Susceptibility
    Sumanun Suwunnakorn, Hironao Wakabayashi, Milena Kordalewska, David S. Perlin, Elena P. Rustchenko · 2018 · Antimicrobial Agents and Chemotherapy
14. Regulation of azole drug susceptibility by Candida albicans protein kinase CK2
    Vincent M. Bruno, Aaron P. Mitchell · 2005 · Molecular Microbiology
15. Development of Candidemia on Caspofungin Therapy: a Case Report
    C. N. Cheung, Yi Guo, Phillip Gialanella, Marta Feldmesser · 2006 · Infection
16. A chromosome 4 trisomy contributes to increased fluconazole resistance in a clinical isolate of Candida albicans
    Anderson, Matthew Z., Saha, Amrita, Haseeb, Abid, Bennett, Richard J. · 2017 · Microbiology
17. <i>UPC2A</i> Is Required for High-Level Azole Antifungal Resistance in Candida glabrata
    Whaley, Sarah G., Caudle, Kelly E., Vermitsky, John-Paul, Chadwick, Sean G., Toner, Geoffrey, Barker, Katherine S., Gygax, Scott E., Rogers, P. David · 2014 · Antimicrobial Agents and Chemotherapy
18. Signaling through Lrg1, Rho1 and Pkc1 Governs Candida albicans Morphogenesis in Response to Diverse Cues
    Jinglin Lucy Xie, Nora Grahl, Trevor J. L. Sless, Michelle D. Leach, Sang Hu Kim, Deborah A. Hogan, Nicole Robbins, Leah E. Cowen · 2016 · PLoS Genetics
19. Mediator Tail Module Is Required for Tac1-Activated <i>CDR1</i> Expression and Azole Resistance in Candida albicans
    Liu, Zhongle, Myers, Lawrence C. · 2017 · Antimicrobial Agents and Chemotherapy
20. Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced <i>MDR1</i> Expression and Fluconazole Resistance
    Liu, Zhongle, Myers, Lawrence C. · 2017 · Antimicrobial Agents and Chemotherapy
21. The RAM1 gene encoding a protein-farnesyltransferase β-subunit homologue is essential in Cryptococcus neoformans
    Marcelo Afonso Vallim, Larissa Fernandes, J. Andrew Alspaugh · 2004 · Microbiology
22. Stable Phenotypic Resistance of Candida Species to Amphotericin B Conferred by Preexposure to Subinhibitory Levels of Azoles
    José A. Vázquez, Maria T. Arganoza, Dina A. Boikov, Stephanie A. Yoon, Jack D. Sobel, Robert A. Akins · 1998 · Journal of Clinical Microbiology
23. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity
    Kyoko Niimi, Brian C. Monk, Asuka Hirai, Kazuaki Hatakenaka, Takashi Umeyama, Erwin Lamping, Katsuyuki Maki, Koichi Tanabe, Tomohiko Kamimura, Fumiaki Ikeda et al. · 2010 · Journal of Antimicrobial Chemotherapy
24. Parasex Generates Phenotypic Diversity <i>de Novo</i> and Impacts Drug Resistance and Virulence in <i>Candida albicans</i>
    Hirakawa, Matthew P, Chyou, Darius E, Huang, Denis, Slan, Aaron R, Bennett, Richard J · 2017 · Genetics
25. Identification of Genomic Binding Sites for Candida glabrata Pdr1 Transcription Factor in Wild-Type and ρ ⁰ Cells
    Paul, Sanjoy, Bair, Thomas B., Moye-Rowley, W. Scott · 2014 · Antimicrobial Agents and Chemotherapy
26. Extensive functional redundancy in the regulation of C andida albicans drug resistance and morphogenesis by lysine deacetylases H os2, H da1, R pd3 and R pd31
    Xinliu Li, Nicole Robbins, Teresa R. O’Meara, Leah E. Cowen · 2016 · Molecular Microbiology
27. The Rim pathway mediates antifungal tolerance in Candida albicans through newly identified Rim101 transcriptional targets, including Hsp90 and Ipt1
    Garnaud, Cécile, García-Oliver, Encar, Wang, Yan, Maubon, Danièle, Bailly, Sébastien, Despinasse, Quentin, Champleboux, Morgane, Govin, Jérôme, Cornet, Muriel · 2018 · Antimicrobial Agents and Chemotherapy
28. Metabolic control of antifungal drug resistance
    Robbins, Nicole, Collins, Cathy, Morhayim, Jess, Cowen, Leah E. · 2010 · Fungal Genetics and Biology
29. Amphotericin B induces trehalose synthesis and simultaneously activates an antioxidant enzymatic response in Candida albicans
    Pilar González Párraga, Ruth Sánchez-Fresneda, Óscar Zaragoza, Juan Carlos Argüelles · 2011 · Biochimica et Biophysica Acta (BBA) - General Subjects
30. RAM2: an essential gene in the prenylation pathway of Candida albicans
    Song, J. L. · 2003 · Microbiology
31. A pre-therapeutic coating for medical devices that prevents the attachment of Candida albicans
    Diego A. Vargas-Blanco, Aung Lynn, Jonah C. Rosch, Rony M. Noreldin, Anthony A. Salerni, Christopher Lambert, Reeta P. Rao · 2017 · Annals of Clinical Microbiology and Antimicrobials
32. Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs
    Mount, Harley O’Connor, Revie, Nicole M., Todd, Robert T., Anstett, Kaitlin, Collins, Cathy, Costanzo, Michael, Boone, Charles, Robbins, Nicole, Selmecki, Anna, Cowen, Leah E. · 2018 · PLOS Genetics
33. The vaccines and antibodies associated with Als3p for treatment of Candida albicans infections.
    Xue Sui, Lan Yan, Yuan-Ying Jiang · 2017 · Vaccine
34. Comparative genomic and transcriptomic analyses unveil novel features of azole resistance and adaptation to the human host in Candida glabrata
    Salazar, Sara Barbosa, Wang, Can, Münsterkötter, Martin, Okamoto, Michiyo, Takahashi-Nakaguchi, Azusa, Chibana, Hiroji, Lopes, Maria Manuel, Güldener, Ulrich, Butler, Geraldine, Mira, Nuno Pereira · 2018 · FEMS Yeast Research
35. A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance
    Yongqin Wu, Ning Gao, Cui Li, Jing Qing Gao, Chunmei Ying · 2017 · FEMS Yeast Research
36. Candida auris: The Canary in the Mine of Antifungal Drug Resistance
    Marhiah C. Montoya, Scott Moye-Rowley, Damian J. Krysan · 2019 · ACS Infectious Diseases
37. In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida
    Jianjun Qiao, Peiping Gao, Xiaoling Jiang, Hong Fang · 2013 · Annals of Clinical Microbiology and Antimicrobials